Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Revisiting total recognition discriminability in Huntington's and Alzheimer's disease: New insights from the CVLT-3.

Graves LV, Simone S, Williams M, Courville T, Mattson SN, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE.

Appl Neuropsychol Adult. 2019 May 6:1-8. doi: 10.1080/23279095.2019.1605993. [Epub ahead of print]

PMID:
31060389
2.

Total recognition discriminability in Huntington's and Alzheimer's disease.

Graves LV, Holden HM, Delano-Wood L, Bondi MW, Woods SP, Corey-Bloom J, Salmon DP, Delis DC, Gilbert PE.

J Clin Exp Neuropsychol. 2017 Mar;39(2):120-130. doi: 10.1080/13803395.2016.1204993. Epub 2016 Jul 21.

3.

New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease.

Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE.

J Int Neuropsychol Soc. 2018 Sep;24(8):833-841. doi: 10.1017/S1355617718000474. Epub 2018 Aug 16.

4.

Identifying the "source" of recognition memory deficits in patients with Huntington's disease or Alzheimer's disease: evidence from the CVLT-II.

Fine EM, Delis DC, Wetter SR, Jacobson MW, Hamilton JM, Peavy G, Goldstein J, McDonald C, Corey-Bloom J, Bondi MW, Salmon DP.

J Clin Exp Neuropsychol. 2008 May;30(4):463-70. doi: 10.1080/13803390701531912.

5.

New Intrusion Analyses on the CVLT-3: Utility in Distinguishing the Memory Disorders of Alzheimer's versus Huntington's Disease.

Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Gilbert PE, Delis DC.

J Int Neuropsychol Soc. 2019 May 7:1-6. doi: 10.1017/S1355617719000407. [Epub ahead of print]

PMID:
31060638
6.

Refining CVLT-II recognition discriminability indices to enhance the characterization of recognition memory changes in healthy aging.

Graves LV, Van Etten EJ, Holden HM, Delano-Wood L, Bondi MW, Corey-Bloom J, Delis DC, Gilbert PE.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2018 Sep;25(5):767-782. doi: 10.1080/13825585.2017.1372358. Epub 2017 Aug 31.

PMID:
28857679
7.

Recall discriminability: utility of a new CVLT-II measure in the differential diagnosis of dementia.

Delis DC, Wetter SR, Jacobson MW, Peavy G, Hamilton J, Gongvatana A, Kramer JH, Bondi MW, Corey-Bloom J, Salmon DP.

J Int Neuropsychol Soc. 2005 Oct;11(6):708-15.

PMID:
16248906
8.

Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group.

Peavy G, Jacobs D, Salmon DP, Butters N, Delis DC, Taylor M, Massman P, Stout JC, Heindel WC, Kirson D, et al.

J Clin Exp Neuropsychol. 1994 Aug;16(4):508-23.

PMID:
7962355
9.

The Hopkins Verbal Learning Test and CVLT: a preliminary comparison.

Lacritz LH, Cullum CM.

Arch Clin Neuropsychol. 1998 Oct;13(7):623-8.

PMID:
14590623
10.

Where have I heard that before? A validity study of source memory indices from the California Verbal Learning Test - Second edition.

Babicz MA, Sheppard DP, Morgan EE, Paul Woods S.

Clin Neuropsychol. 2019 May 14:1-20. doi: 10.1080/13854046.2019.1613559. [Epub ahead of print]

PMID:
31084399
11.

Effects of Age and Gender on Recall and Recognition Discriminability.

Graves LV, Moreno CC, Seewald M, Holden HM, Van Etten EJ, Uttarwar V, McDonald CR, Delano-Wood L, Bondi MW, Woods SP, Delis DC, Gilbert PE.

Arch Clin Neuropsychol. 2017 Dec 1;32(8):972-979. doi: 10.1093/arclin/acx024.

12.

Cholinesterase inhibitors for rarer dementias associated with neurological conditions.

Li Y, Hai S, Zhou Y, Dong BR.

Cochrane Database Syst Rev. 2015 Mar 3;(3):CD009444. doi: 10.1002/14651858.CD009444.pub3. Review.

PMID:
25734590
13.

Is verbal recognition memory really different in Huntington's and Alzheimer's disease.

Brandt J, Corwin J, Krafft L.

J Clin Exp Neuropsychol. 1992 Sep;14(5):773-84.

PMID:
1474145
14.

Are the original and second edition of the California Verbal Learning Test equally accurate in detecting malingering?

Greve KW, Curtis KL, Bianchini KJ, Ord JS.

Assessment. 2009 Sep;16(3):237-48. doi: 10.1177/1073191108326227. Epub 2008 Dec 19.

PMID:
19098280
15.

Yes/no versus forced-choice recognition memory in mild cognitive impairment and Alzheimer's disease: patterns of impairment and associations with dementia severity.

Clark LR, Stricker NH, Libon DJ, Delano-Wood L, Salmon DP, Delis DC, Bondi MW.

Clin Neuropsychol. 2012;26(7):1201-16. doi: 10.1080/13854046.2012.728626. Epub 2012 Oct 2.

16.

Criterion validity of the California Verbal Learning Test-Second Edition (CVLT-II) after traumatic brain injury.

Jacobs ML, Donders J.

Arch Clin Neuropsychol. 2007 Feb;22(2):143-9. Epub 2007 Jan 4.

17.

Error analysis of the nine-word California Verbal Learning Test (CVLT-9) among older adults with and without dementia.

Davis KL, Price CC, Kaplan E, Libon DJ.

Clin Neuropsychol. 2002 Feb;16(1):81-9.

PMID:
11992230
18.

Embedded performance validity indicators within the California Verbal Learning Test, Children's Version.

Baker DA, Connery AK, Kirk JW, Kirkwood MW.

Clin Neuropsychol. 2014;28(1):116-27. doi: 10.1080/13854046.2013.858184. Epub 2013 Nov 15.

PMID:
24229006
19.

Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer's disease and ischaemic vascular dementia.

Libon DJ, Bogdanoff B, Cloud BS, Skalina S, Giovannetti T, Gitlin HL, Bonavita J.

J Clin Exp Neuropsychol. 1998 Feb;20(1):30-41.

PMID:
9672817
20.

The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.

Davis MY, Keene CD, Jayadev S, Bird T.

J Huntingtons Dis. 2014;3(2):209-17. doi: 10.3233/JHD-140111.

PMID:
25062863

Supplemental Content

Support Center